metoprolol has been researched along with Sinus Tachycardia in 11 studies
Metoprolol: A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.
metoprolol : A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ivabradine is a new agent inhibiting sinus node I(f) current, resulting in a decrease of HR without haemodynamic compromise." | 6.78 | Metoprolol succinate vs. ivabradine in the treatment of inappropriate sinus tachycardia in patients unresponsive to previous pharmacological therapy. ( Kaczmarek, K; Klingenheben, T; Ptaszynski, P; Ruta, J; Wranicz, JK, 2013) |
| "Inappropriate sinus tachycardia (IST) is a clinical syndrome characterized by excessive resting heart rate (HR) or a disproportional increase in HR during exercise." | 5.39 | Ivabradine in combination with metoprolol succinate in the treatment of inappropriate sinus tachycardia. ( Cygankiewicz, I; Kaczmarek, K; Klingenheben, T; Ptaszynski, P; Ruta, J; Wranicz, JK, 2013) |
| "Treatment with ivabradine in patients within 2 years after HTX significantly reduced post-transplant heart rate and LV mass and was associated with a superior survival in comparison with patients receiving metoprolol succinate." | 1.48 | Control of cardiac chronotropic function in patients after heart transplantation: effects of ivabradine and metoprolol succinate on resting heart rate in the denervated heart. ( Bruckner, T; Darche, FF; Doesch, AO; Ehlermann, P; Helmschrott, M; Katus, HA; Rahm, AK; Rivinius, R; Ruhparwar, A; Thomas, D, 2018) |
| "A metoprolol therapy was established, however to resistant tachycardia, we suggested a combined therapy of Bisoprolol and Ivabradin, which resulted successfully in normocard sinus rhythm." | 1.40 | [A heart without overspeed trip unit]. ( Gähwiler, R; Ghadri, JR; Lüscher, TF; Templin, C, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 7 (63.64) | 24.3611 |
| 2020's | 3 (27.27) | 2.80 |
| Authors | Studies |
|---|---|
| Rajendram, R | 1 |
| AlDhahri, F | 1 |
| Mahmood, N | 1 |
| Kharal, M | 1 |
| Rivinius, R | 2 |
| Helmschrott, M | 2 |
| Rahm, AK | 2 |
| Darche, FF | 2 |
| Thomas, D | 2 |
| Bruckner, T | 2 |
| Doesch, AO | 2 |
| Katus, HA | 2 |
| Ehlermann, P | 2 |
| Aurora, L | 1 |
| Nona, P | 1 |
| Ananthasubramaniam, K | 1 |
| Ruhparwar, A | 1 |
| Ptaszynski, P | 2 |
| Kaczmarek, K | 2 |
| Ruta, J | 2 |
| Klingenheben, T | 2 |
| Cygankiewicz, I | 1 |
| Wranicz, JK | 2 |
| Gähwiler, R | 1 |
| Templin, C | 1 |
| Lüscher, TF | 1 |
| Ghadri, JR | 1 |
| Zayac, A | 1 |
| Shah, R | 1 |
| Shah, M | 1 |
| Umar, J | 1 |
| Bansal, N | 1 |
| Dhamoon, A | 1 |
| Richardson, ES | 1 |
| Rolfes, C | 1 |
| Woo, OS | 1 |
| Elmquist, WF | 1 |
| Benditt, DG | 1 |
| Iaizzo, PA | 1 |
| Wichterle, D | 1 |
| Prendergast, HM | 1 |
| Soorya, N | 1 |
| Erickson, T | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Comparison of Ivabradine and Beta-blockers Administration in the Treatment of Inappropriate Sinus Tachycardia[NCT01657136] | Phase 3 | 20 participants (Actual) | Interventional | 2013-09-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for metoprolol and Sinus Tachycardia
| Article | Year |
|---|---|
Metoprolol succinate vs. ivabradine in the treatment of inappropriate sinus tachycardia in patients unresponsive to previous pharmacological therapy.
Topics: Adrenergic beta-Antagonists; Adult; Anti-Arrhythmia Agents; Benzazepines; Female; Humans; Ivabradine | 2013 |
10 other studies available for metoprolol and Sinus Tachycardia
| Article | Year |
|---|---|
The use of ivabradine in a patient with inappropriate sinus tachycardia and cardiomyopathy due to limb girdle muscular dystrophy type 2I.
Topics: Anti-Arrhythmia Agents; Cardiomyopathies; Cardiovascular Agents; Diagnosis, Differential; Female; Hu | 2020 |
Five-year results of heart rate control with ivabradine or metoprolol succinate in patients after heart transplantation.
Topics: Anti-Arrhythmia Agents; Female; Heart Rate; Heart Transplantation; Humans; Ivabradine; Male; Metopro | 2022 |
A Pregnant Patient with Elevated Heart Rate.
Topics: Anti-Arrhythmia Agents; Female; Fluid Therapy; Heart Rate; Humans; Metoprolol; Pregnancy; Pregnancy | 2021 |
Control of cardiac chronotropic function in patients after heart transplantation: effects of ivabradine and metoprolol succinate on resting heart rate in the denervated heart.
Topics: Adult; Anti-Arrhythmia Agents; Benzazepines; Female; Germany; Heart; Heart Rate; Heart Transplantati | 2018 |
Ivabradine in combination with metoprolol succinate in the treatment of inappropriate sinus tachycardia.
Topics: Adrenergic beta-Antagonists; Adult; Benzazepines; Drug Resistance; Drug Therapy, Combination; Electr | 2013 |
[A heart without overspeed trip unit].
Topics: Adult; Algorithms; Benzazepines; Bisoprolol; Diagnosis, Differential; Drug Therapy, Combination; Ech | 2014 |
Thyrotoxic hypokalemic periodic paralysis.
Topics: Adult; Anti-Arrhythmia Agents; Antithyroid Agents; Humans; Hypokalemic Periodic Paralysis; Male; Met | 2016 |
Cardiac responses to the intrapericardial delivery of metoprolol: targeted delivery compared to intravenous administration.
Topics: Animals; Anti-Arrhythmia Agents; Atrial Function, Right; Blood Pressure; Disease Models, Animal; Ele | 2012 |
Ivabradine for inappropriate sinus tachycardia: another piece of evidence.
Topics: Benzazepines; Female; Humans; Ivabradine; Male; Metoprolol; Tachycardia, Sinus | 2013 |
Sudden death after IV metoprolol administration in a patient with cardiomyopathy.
Topics: Adrenergic beta-Antagonists; Adult; Alcoholism; Cardiomyopathy, Dilated; Death, Sudden, Cardiac; Ele | 2004 |